Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus
NCT03059719
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Type II Diabetes Mellitus
Interventions
BIOLOGICAL:
Exenatide injection(Byetta)
BIOLOGICAL:
PB-119 injection
Sponsor
PegBio Co., Ltd.